去年ASCO披露的数_老虎社区_美港股上老虎

去年ASCO披露的数据中，看到 PD-L1 阴性患者 ORR 54.5%，这意味着不挑患者，无论 PD-L1 表达如何都能从LBL-024获益，适用人群更广，维立志博的商业空间也更大

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":441163242848280,"tweetId":"441163242848280","gmtCreate":1748744255998,"gmtModify":1748744257662,"author":{"id":4090740707034800,"idStr":"4090740707034800","authorId":4090740707034800,"authorIdStr":"4090740707034800","name":"在能力圈内做事","avatar":"https://static.tigerbbs.com/eae913210ead37534ccd6a5658b225e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>去年ASCO披露的数据中，看到 PD-L1 阴性患者 ORR 54.5%，这意味着不挑患者，无论 PD-L1 表达如何都能从LBL-024获益，适用人群更广，维立志博的商业空间也更大</body></html>","htmlText":"<html><head></head><body>去年ASCO披露的数据中，看到 PD-L1 阴性患者 ORR 54.5%，这意味着不挑患者，无论 PD-L1 表达如何都能从LBL-024获益，适用人群更广，维立志博的商业空间也更大</body></html>","text":"去年ASCO披露的数据中，看到 PD-L1 阴性患者 ORR 54.5%，这意味着不挑患者，无论 PD-L1 表达如何都能从LBL-024获益，适用人群更广，维立志博的商业空间也更大","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/441163242848280","repostId":0,"isVote":1,"tweetType":1,"viewCount":832,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":136,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/441163242848280"}